BofA lowered the firm’s price target on CME Group (CME) to $239 from $241 and keeps an Underperform rating on the shares. The firm is updating EPS estimates to embed volume and fee rate disclosures and making modest modeling revisions ahead of U.S. exchange earnings over the next few weeks, the analyst tells investors in a preview for the group.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- Morning Movers: Best Buy dips after CEO transition announcement
- CME Group reports Q1 adjusted EPS $3.36, consensus $3.38
- These Are the Stocks Reporting Earnings Today – April 22, 2026
- CME Group Inc (CME) Q1 Earnings Cheat Sheet
- CME Group and DTCC’s cross-margining arrangement approved by SEC and CFTC